Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 6.60
+0.01 (0.08%)
Nov 11, 2026, 4:08 PM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 2.81 billion as of November 10, 2026. It is the 16,944th most valuable company in the world and the 750th biggest in Hong Kong. Its market cap has decreased by 36.32% in one year.
Market Cap
2.81B
Enterprise Value
1.70B
Revenue
296.69M
Global Rank
Country Rank
#750 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 2.81B, a decrease of -51.93%. That is a compound annual growth rate of -19.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 2.81B | -50.44% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TenNor Therapeutics (Suzhou) | 3.45B |
| Qyuns Therapeutics | 3.31B |
| TransThera Sciences (Nanjing) | 3.29B |
| Beijing Luzhu Biotechnology | 3.06B |
| Frontage Holdings | 3.03B |
| Shanghai Bao Pharmaceuticals | 2.84B |
| Medtide | 2.84B |
| Viva Biotech Holdings | 2.75B |